Breast implant capsule-associated squamous cell carcinoma: case report

Breast augmentation with the use of silicone breast implants is a routine practice for breast surgeons. Breast implant capsule-associated squamous cell carcinoma is a rare and aggressive malignant tumor accounting for less than 0,1 % of invasive breast cancer. Currently there is no single concept of a complex therapy for such tumors due to the low incidence rate. The article describes a case of a 49-year-old female patient after surgical treatment of left-sided breast implant capsule-associated squamous cell carcinoma diagnosed in 2019. After the disease progression the patient underwent removal of the chest wall tumor with resection of ribs 3-5, allo-and autoplasty, and left axillary lymph node dissection (ALND). In most cases, breast implant capsule-associated squamous cell carcinoma is treated surgically but the role of adjuvant chemotherapy, radiation therapy, and endocrine therapy is still ambiguous.